ONCAlert | 2017 NANETS Symposium

The Best Therapy Option for a Patient With mCRPC

Raoul Concepcion, MD
Published Online:1:24 PM, Mon November 28, 2016

Raoul Concepcion, MD, director, Comprehensive Prostate Center, discussed the best treatment option for a patient with metasatic castration-resistant prostate cancer (mCRPC) during the LUGPA Annual Meeting.
Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.